Drug
Bay1817080
Bay1817080: highest development phase Phase 1, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| BAY1817080 NCT04454424 | Phase 1 | Endometriosis Related Pain |
Latest
No recent events.
Follow Bay1817080 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.